Filing Details
- Accession Number:
- 0001437749-21-009953
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2021-04-28 08:31:16
- Reporting Period:
- 2019-12-31
- Accepted Time:
- 2021-04-28 08:31:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653821 | Cen Biotech Inc | CENBF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1736940 | Richard Boswell | 300-3295 Quality Way Windsor, Ontario, Canada A6 N8T 3R9 | Senior Executive Vp | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-04-26 | 60,000 | $0.25 | 3,878,571 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-04-26 | 40,000 | $0.25 | 3,878,571 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-16 | 500,000 | $0.18 | 3,878,571 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-11-17 | 25,000 | $0.80 | 3,878,571 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-11-17 | 25,000 | $0.80 | 3,878,571 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-31 | 12,500 | $0.80 | 3,878,571 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |